Improved Production of Anti-FGF-2 Nanobody Using Pichia pastoris and Its Effect on Antiproliferation of Keratinocytes and Alleviation of Psoriasis

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

(2022) Xue Zhou et al.   Cell Death & Disease

Advances in antibody phage display technology

(2022) Line Ledsgaard et al.   DRUG DISCOVERY TODAY

Enhanced Recombinant Protein Production of Soluble, Highly Active and Immobilizable PNGase F

(2022) Noémi Kovács et al.   MOLECULAR BIOTECHNOLOGY

Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model

(2022) Jiaxuan Tang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Nanobody—A versatile tool for cancer diagnosis and therapeutics

(2021) Manman Liu et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Immunotherapy in psoriasis

(2021) Lilla Landeck et al.   Immunotherapy

L-Theanine Alleviates IMQ-Induced Psoriasis Like Skin Inflammation by Downregulating the Production of IL-23 and Chemokines

(2021) Yaohan Xu et al.   Frontiers in Pharmacology

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

(2020) April W. Armstrong et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Change of Amino Acid Residues in Idiotypic Nanobodies Enhanced the Sensitivity of Competitive Enzyme Immunoassay for Mycotoxin Ochratoxin A in Cereals

(2020) Caixia Zhang et al.   Toxins

miR124-3p/FGFR2 axis inhibits human keratinocyte proliferation and migration and improve the inflammatory microenvironment in psoriasis

(2020) Yueyuan Xiao et al.   MOLECULAR IMMUNOLOGY

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics

(2020) Emily Y. Yang et al.   Frontiers in Oncology

Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours

(2020) Long Wang et al.   Recent Patents on Anti-Cancer Drug Discovery

Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model

(2020) Mehwish Jabeen et al.   Pharmaceutics

A randomized, double-blind, placebo-controlled phase 1 study of multiple ascending doses of subcutaneous M1095, an anti-interleukin-17A/F Nanobody®, in moderate-to-severe psoriasis

(2019) Danka Svecova et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes

(2019) Sonja Moos et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Nanobody: outstanding features for diagnostic and therapeutic applications

(2019) J.-Pablo Salvador et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis

(2019) H.‐J. Shi et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis Pathogenesis: Keratinocytes Are Back in the Spotlight

(2019) Natalie Garzorz-Stark et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer

(2019) Francesca Battaglin et al.   Cancer Management and Research

The Therapeutic Potential of Nanobodies

(2019) Ivana Jovčevska et al.   BIODRUGS

Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models

(2019) Bo-Wen Jiang et al.   BIOMEDICINE & PHARMACOTHERAPY

Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes

(2018) Ye-Hong Kuang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

(2018) Hui Li et al.   Nature Communications

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

(2018) Isabel Haugh et al.   Drug Design Development and Therapy

Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy

(2017) Yaozhong Hu et al.   Frontiers in Immunology

Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer

(2016) L. Paz-Ares et al.   ANNALS OF ONCOLOGY

Camelid-derived heavy-chain nanobody againstClostridium botulinumneurotoxin E inPichia pastoris

(2016) Roghayyeh Baghban et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Flow cytometric analysis of T lymphocyte proliferation in vivo by EdU incorporation

(2016) Xiaojing Sun et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Nanobody-based cancer therapy of solid tumors

(2015) Marta Kijanka et al.   Nanomedicine

Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation

(2015) Xiaoping Wu et al.   Oncotarget

Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production

(2014) Mudassar Ahmad et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Featured Article: Autophagic activation with Nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma

(2014) Haizhu Song et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

N-glycosylation deficiency enhanced heterologous production of a Bacillus licheniformis thermostable α-amylase in Saccharomyces cerevisiae

(2013) Hisashi Hoshida et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice

(2011) A. B. Van Belle et al.   JOURNAL OF IMMUNOLOGY

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

(2010) Jolien Tol et al.   CLINICAL THERAPEUTICS

Epidermal growth factor receptor inhibitors in oncology

(2010) Igor Vivanco et al.   CURRENT OPINION IN ONCOLOGY

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY

Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis

(2009) Erin G. Harper et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia A Mice

(2009) Aaron Peng et al.   JOURNAL OF PHARMACEUTICAL SCIENCES